Cargando…

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices

BACKGROUND: There is urgent need for effective HIV prevention methods that women can initiate. The CAPRISA 004 trial showed that a tenofovir-based vaginal microbicide had significant impact on HIV incidence among women. This study uses the trial findings to estimate the population-level impact of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Terris-Prestholt, Fern, Foss, Anna M, Cox, Andrew P, Heise, Lori, Meyer-Rath, Gesine, Delany-Moretlwe, Sinead, Mertenskoetter, Thomas, Rees, Helen, Vickerman, Peter, Watts, Charlotte H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899035/ https://www.ncbi.nlm.nih.gov/pubmed/24405719 http://dx.doi.org/10.1186/1471-2334-14-14

Ejemplares similares

The cost‐effectiveness of multi‐purpose HIV and pregnancy prevention technologies in South Africa
por: Quaife, Matthew, et al.
Publicado: (2018)

The effect of HIV prevention products on incentives to supply condomless commercial sex among female sex workers in South Africa
por: Quaife, Matthew, et al.
Publicado: (2018)

Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment
por: Quaife, Matthew, et al.
Publicado: (2016)

How Much Demand for New HIV Prevention Technologies Can We Really Expect? Results from a Discrete Choice Experiment in South Africa
por: Terris-Prestholt, Fern, et al.
Publicado: (2013)

Parameterising User Uptake in Economic Evaluations: The role of discrete choice experiments
por: Terris‐Prestholt, Fern, et al.
Publicado: (2016)

The cost of safe sex: estimating the price premium for unprotected sex during the Avahan HIV prevention programme in India
por: Quaife, Matthew, et al.
Publicado: (2019)

Financing Essential HIV Services: A New Economic Agenda
por: Vassall, Anna, et al.
Publicado: (2013)

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
por: Jamieson, Lise, et al.
Publicado: (2022)

Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
por: Cheng, Chih-Yuan, et al.
Publicado: (2019)

HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection
por: Vickerman, Peter, et al.
Publicado: (2020)

Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study
por: Mitchell, Kate M, et al.
Publicado: (2016)

Investing in the future: lessons learnt from communicating the results of HSV/ HIV intervention trials in South Africa
por: Delany-Moretlwe, Sinead, et al.
Publicado: (2011)

Using Societal Values to Inform Public Health Policy During the COVID-19 Pandemic: The Role of Health Preference Research
por: DiSantostefano, Rachael L., et al.
Publicado: (2021)

Using HPV vaccination for promotion of an adolescent package of care: opportunity and perspectives
por: MacPhail, Catherine, et al.
Publicado: (2013)

Advancing STI priorities in the SDG era: priorities for action
por: Chersich, Matthew F., et al.
Publicado: (2018)

At the Heart of the Problem: Health in Johannesburg’s Inner-City
por: Rees, Helen, et al.
Publicado: (2017)

Designing a package of sexual and reproductive health and HIV outreach services to meet the heterogeneous preferences of young people in Malawi: results from a discrete choice experiment
por: Michaels-Igbokwe, Christine, et al.
Publicado: (2015)

Heterogeneity in individual preferences for HIV testing: A systematic literature review of discrete choice experiments
por: Sharma, Monisha, et al.
Publicado: (2020)

Mucosal effects of tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015)

Estimated changes in price discounts for tenofovir-inclusive HIV treatments following introduction of tenofovir alafenamide
por: Dickson, Sean, et al.
Publicado: (2022)

The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis
por: Jamieson, Lise, et al.
Publicado: (2021)

Alcohol use and sexual risk behaviour among men and women in inner-city Johannesburg, South Africa
por: Bello, Braimoh, et al.
Publicado: (2017)

Young People’s Preferences for Family Planning Service Providers in Rural Malawi: A Discrete Choice Experiment
por: Michaels-Igbokwe, Christine, et al.
Publicado: (2015)

Cost-Effectiveness of Introducing the SILCS Diaphragm in South Africa
por: Lépine, Aurélia, et al.
Publicado: (2015)

‘It’s not about money, it’s about my health’: determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa
por: MacPhail, Catherine, et al.
Publicado: (2012)

‘I heard about this study on the radio’: using community radio to strengthen Good Participatory Practice in HIV prevention trials
por: Medeossi, Bonnie-Jeanne, et al.
Publicado: (2014)

Advancing use of long‐acting and extended delivery HIV prevention and treatment regimens
por: Delany‐Moretlwe, Sinéad, et al.
Publicado: (2023)

Optimising the cost and delivery of HIV counselling and testing services in Kenya and Swaziland
por: Obure, Carol Dayo, et al.
Publicado: (2012)

The cost-effectiveness of 10 antenatal syphilis screening and treatment approaches in Peru, Tanzania, and Zambia
por: Terris-Prestholt, Fern, et al.
Publicado: (2015)

Correction: Mucosal effects for tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015)

Vaginal deployment and tenofovir delivery by microbicide gels
por: Gao, Y., et al.
Publicado: (2015)

Modelling costs of community-based HIV self-testing programmes in Southern Africa at scale: an econometric cost function analysis across five countries
por: d'Elbée, Marc, et al.
Publicado: (2021)

Cost-effectiveness of Hepatitis C virus self-testing in four settings
por: Walker, Josephine G., et al.
Publicado: (2023)

The cost and intermediary cost-effectiveness of oral HIV self-test kit distribution across 11 distribution models in South Africa
por: Matsimela, Katleho, et al.
Publicado: (2021)

Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria
por: Mitchell, Kate M., et al.
Publicado: (2015)

Transactional sex among young women in rural South Africa: prevalence, mediators and association with HIV infection
por: Ranganathan, Meghna, et al.
Publicado: (2016)

Collateral benefits: how the practical application of Good Participatory Practice can strengthen HIV research in sub‐Saharan Africa
por: Baron, Deborah, et al.
Publicado: (2018)

Secondary distribution of HIV self-test kits by HIV index and antenatal care clients: implementation and costing results from the STAR Initiative in South Africa
por: Zishiri, Vincent, et al.
Publicado: (2023)

Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale
por: Quentin, Wilm, et al.
Publicado: (2011)

Can the UNAIDS modes of transmission model be improved?: a comparison of the original and revised model projections using data from a setting in west Africa
por: Prudden, Holly J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i7vg9jor3sgvquqe0nd8c9glft